(calcitonin-salmon)--a nasal spray--has been shown to increase spinal bone mass in postmenopausal women with osteoporosis.
For people who can't or won't take estrogen replacement drugs or Fosamax, Miacalcin
nasal spray is a good alternative.
The company sells Miacalcin
nasal spray for the condition.
The scheduled patent expiries of Reclast, Fosamax, Miacalcin
and Actonel are expected to further affect the PDB market by leaving it vulnerable to generics.
from Novartis Pharmaceuticals and Fortical from Upsher-Smith Laboratories both treat osteoporosis; Pfizer's Nicotrol addresses nicotine addiction; Nascobal from Strativa Pharmaceuticals is used to treat vitamin B deficiency; Ferrin.
Q: I turned down Fosamax and Actonel in the past, but did agree to try Miacalcin
Nasal Spray for osteoporosis prevention.
In women who are more Brand name: than 5 years beyond Miacalcin
menopause, calcitonin slows bone loss, increases spinal bone density and may relieve the pain asso- ciated with bone fractures.
[R] is administered by injection; 50 to 100 units daily or 3 times per week for 6-18 months.
The Phase I study was an open label single dose cross-over trial to assess the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of ViaDerm-Calcitonin in 12 postmenopausal women treated with 4 different transdermal Calcitonin doses (60-300 mcg) compared to 100IU of Miacalcin
, the subcutaneous injected form of the Calcitonin.
The market will witness generic erosion owing to the patent expiry of products such as Actonel Reclast and Miacalcin